Skip to main content
Clinical Trials/ChiCTR2100050202
ChiCTR2100050202
Active, not recruiting
Phase 1

七氟烷和丙泊酚对急诊外伤术后创伤后应激障碍发病的影响

苏州市科技发展计划项目(SYSD2019062)5 sites in 1 country300 target enrollmentStarted: August 20, 2021Last updated:

Overview

Phase
Phase 1
Status
Active, not recruiting
Sponsor
苏州市科技发展计划项目(SYSD2019062)
Enrollment
300
Locations
5
Primary Endpoint
创伤后应激障碍发生率

Overview

Brief Summary

研究两种主要全身麻醉药物丙泊酚、七氟烷对急诊外伤患者术后创伤后应激障碍发病率的影响。

Study Design

Study Type
干预性研究
Primary Purpose
随机平行对照
Masking
None

Eligibility Criteria

Ages
18 to 60 (—)
Sex
All

Inclusion Criteria

  • 急诊外伤:车祸、坠落、工程事故等;
  • ASA I-III 级;

Exclusion Criteria

  • 2.失血性休克失代偿;
  • 4.酗酒史或药物依赖史;
  • 5.神经或精神疾病史;
  • 6.严重的视力、听力或语言障碍;
  • 7.既往存在重大躯体或精神创伤。

Arms & Interventions

丙泊酚组

丙泊酚麻醉维持

七氟烷组

七氟烷麻醉维持

Outcomes

Primary Outcomes

创伤后应激障碍发生率

Time Frame: 术后 30 天

Secondary Outcomes

  • 术后疼痛、谵妄、恶心、瘙痒
  • 人口统计资料和手术相关参数

Investigators

Sponsor
苏州市科技发展计划项目(SYSD2019062)

Study Sites (5)

Loading locations...

Similar Trials